VA-GLA Infectious Diseases
  • Home
  • News
  • Services
  • ASP Main Page Antibiotic Approvals Antibiotics Restricted to Guidelines Switching from IV to PO Antibiotic Timeouts Rapid Diagnostics at GLA ID in seconds
  • GLA Guidelines Needlestick Injury TB Isolation
  • Susceptibilities
  • ID fellow resources
  • Links Board Review slides Teaching Documents

VA-GLA Infectious Diseases

  • Home/
  • News/
  • Services/
  • Stewardship/
    • ASP Main Page
    • Antibiotic Approvals
    • Antibiotics Restricted to Guidelines
    • Switching from IV to PO
    • Antibiotic Timeouts
    • Rapid Diagnostics at GLA
    • ID in seconds
  • Guidelines/
    • GLA Guidelines
    • Needlestick Injury
    • TB Isolation
  • Susceptibilities/
  • ID fellow resources/
  • Other/
    • Links
    • Board Review slides
    • Teaching Documents

VA-GLA Infectious Diseases

VA-GLA Infectious Diseases

New and Noteworthy

VA-GLA Infectious Diseases

  • Home/
  • News/
  • Services/
  • Stewardship/
    • ASP Main Page
    • Antibiotic Approvals
    • Antibiotics Restricted to Guidelines
    • Switching from IV to PO
    • Antibiotic Timeouts
    • Rapid Diagnostics at GLA
    • ID in seconds
  • Guidelines/
    • GLA Guidelines
    • Needlestick Injury
    • TB Isolation
  • Susceptibilities/
  • ID fellow resources/
  • Other/
    • Links
    • Board Review slides
    • Teaching Documents
January 26, 2023

New COVID treatment guidelines (goodbye to Evusheld)

January 26, 2023/ VAGLA Antimicrobial Stewardship Team

GLA COVID treatment protocols have been updated to reflect that EVUSHELD is no longer authorized for COVID prophylaxis in immunocompromised hosts. Head on over to the Guidelines section for the updated version.

January 26, 2023/ VAGLA Antimicrobial Stewardship Team/

VAGLA Antimicrobial Stewardship Team

January 19, 2023

new HIV pre-exposure prophylaxis guidance!

January 19, 2023/ VAGLA Antimicrobial Stewardship Team

New local guidance for HIV pre-exposure prophylaxis (including when to consider cabotegravir) is now available in the “Guidelines” section!

January 19, 2023/ VAGLA Antimicrobial Stewardship Team/

VAGLA Antimicrobial Stewardship Team

November 30, 2022

COVID treatment guideline update

November 30, 2022/ VAGLA Antimicrobial Stewardship Team

New GLA COVID treatment guidelines are posted in the “Guidelines” section that reflect deauthorization of bebtelovimab and weighing evidence of benefit of Evusheld vs. circulating variants.

November 30, 2022/ VAGLA Antimicrobial Stewardship Team/

VAGLA Antimicrobial Stewardship Team

September 29, 2022

New antimicrobial approval phone!

September 29, 2022/ VAGLA Antimicrobial Stewardship Team

The old antimicrobial approval pager has been retired! The new antimicrobial approval phone number is 323-891-5282. Can call or text during regular business hours.

September 29, 2022/ VAGLA Antimicrobial Stewardship Team/

VAGLA Antimicrobial Stewardship Team

August 19, 2022

New monkeypox guidance!

August 19, 2022/ VAGLA Antimicrobial Stewardship Team

New monkeypox guidance is now available under the “Guidelines” tab. More to follow!

August 19, 2022/ VAGLA Antimicrobial Stewardship Team/

VAGLA Antimicrobial Stewardship Team

  • Previous
  • Next